Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neurodegenerative disorders and muscle diseases implicating PUFAs

Neurodegenerative disorders and muscle diseases implicating PUFAs

US Patent 11241409 · Granted Feb 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Disorders implicating PUFA oxidation2024
Site-specific isotopic labeling of 1,4-diene systems2024
Processes for isotopic modification of polyunsaturated fatty acids and derivativ2023
Alleviating oxidative stress disorders with PUFA derivatives2022
Methods for inhibiting the progression of neurodegenerative diseases2022
Methods of treating amyotrophic lateral sclerosis2022
Alleviating oxidative stress disorders with PUFA derivatives2022
Site-specific isotopic labeling of 1,4-diene systems2022
Site-specific isotopic labeling of 1,4-diene systems2022
Methods of treating amyotrophic lateral sclerosis2022
Oxidative retinal diseases2022
Isotopically modified components and therapeutic uses thereof2021